Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Q3 2012 AUM Update

10 Oct 2012 07:00

RNS Number : 3275O
Charlemagne Capital Limited
10 October 2012
 



Charlemagne Capital Limited

 

10 October 2012

 

Charlemagne Capital Announces Unaudited Assets under Management as at 30 September 2012

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the Assets under Management ("AuM") as at 30 September 2012 and the movements for the third quarter of its current financial year.

 

Group AuM

 

Group AuM total up 7.2% in the quarter to US$2.4 billion as at 30 September 2012 reflecting the improved market conditions and net inflows experienced during the most recent quarter.

 

The table below sets out the Group's AuM as at 30 September 2012 and the movements experienced in each product range in the period since 1 July 2012.

 

01-Jul-12

Net Subscriptions

30-Sep-12

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

306

(19)

(6.2)

22

7.4

309

1.0

OCCO

512

56

10.9

3

0.6

571

11.5

Institutional

1,302

(1)

(0.1)

118

9.1

1,419

9.0

Specialist

157

4

2.5

(20)

(12.6)

141

(10.2)

Total

2,277

40

1.8

123

5.4

2,440

7.2

 

 

Notes:

(1) Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first relevant dealing date of the following period.

(2) Net performance includes foreign currency effects for those assets not denominated in US dollars.

 

 

Enquiries:

 

Charlemagne Capital

Jayne Sutcliffe, Chief Executive Tel. 020 7518 2100

Lloyd Jones, Chief Financial Officer Tel. 01624 640200

 

Smithfield Consultants Tel. 020 7360 4900

John Kiely

Ged Brumby

 

Singer Capital Markets (Nominated Adviser) Tel. 020 3205 7500

Jonny Franklin-Adams

Nick Donovan

 

This announcement is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States of America, Australia, Canada, Japan or South Africa or any other jurisdiction into which the release, publication or distribution would be unlawful. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese, South African or other securities law. The distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and persons into whose possession this announcement comes should inform themselves about and observe any such restrictions.

 

This announcement contains (or may contain) certain forward-looking statements with respect to the financial condition, results of operations and businesses of the Group. These statements and forecasts are based on Charlemagne's beliefs, assumptions and expectations of the Group's future performance. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to Charlemagne at the date of this announcement or are within its control, that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Data or statements contained in this announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Nothing in this announcement should be construed as a profit forecast or to imply that the earnings of the Company for the current or future financial years will necessarily match or exceed the historical or published earnings of the Group.

 

This announcement is for information purposes only and shall not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of an offer to buy, sell, issue, or subscribe for, any securities in Charlemagne or any other entity. This announcement is aimed at providing information regarding the Assets under Management on which revenue is derived by Charlemagne. The unaudited data contained in this announcement are currently provisional and all such data are subject to change without notice and, except as required by applicable law, neither Charlemagne nor Singer Capital Markets assumes any responsibility or obligation to update publicly or review any of the data or statements contained herein.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMMGGNLMGZZM
Date   Source Headline
15th Mar 20167:01 amRNSDividend Declaration
15th Mar 20167:00 amRNSFinal Results
17th Feb 20163:07 pmRNSTR1 - Notification of Major Interest in Shares
19th Jan 20167:00 amRNSTrading Statement
27th Nov 201511:28 amRNSForm 8.3 - Al Noor Hospitals Group PLC
26th Nov 201510:42 amRNSForm 8.3 - Al Noor Hospitals Group PLC
25th Nov 201510:48 amRNSForm 8.3 - Al Noor Hospitals Group PLC
23rd Nov 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
19th Nov 201510:56 amRNSForm 8.3 -NMC Health PLC
18th Nov 201511:29 amRNSForm 8.3 - Al Noor Hospitals Group PLC
17th Nov 201510:25 amRNSForm 8.3 - NMC Health PLC
17th Nov 20159:42 amRNSForm 8.3 - Al Noor Hospitals Group PLC
17th Nov 20159:35 amRNSForm 8.3 - NMC Health Plc
9th Nov 201511:38 amRNSForm 8.3 - Al Noor Hospitals
4th Nov 20154:32 pmRNSForm 8.3 - NMC Health Plc
28th Oct 201511:34 amRNSForm 8.3 - Al Noor Hospitals
28th Oct 201511:30 amRNSForm 8.3 - NMC Health PLC
16th Oct 201511:27 amRNSHolding(s) in Company
9th Oct 20157:00 amRNSQ3 2015 AUM Update
22nd Sep 20157:01 amRNSDividend Declaration
22nd Sep 20157:00 amRNSHalf Yearly Report
15th Jul 20157:00 amRNSInterim Management Statement
19th Jun 20156:00 pmRNSHolding(s) in Company
19th Jun 201512:17 pmRNSResult of AGM
15th May 20153:05 pmRNSAnnual Report and Notice of AGM
29th Apr 20156:06 pmRNSHolding(s) in Company
10th Apr 20157:00 amRNSQ1 2015 AUM Update
30th Mar 20159:00 amRNSQuadruple Lipper Award Win for Charlemagne Capital
17th Mar 20157:05 amRNSDividend Declaration
17th Mar 20157:00 amRNSFinal Results
13th Jan 20157:00 amRNSTrading Statement
23rd Dec 20144:28 pmRNSDirector/PDMR Shareholding
10th Oct 20147:00 amRNSQ3 2014 AUM Update
18th Sep 201410:38 amRNSDirector/PDMR Shareholding
17th Sep 201411:46 amRNSDirector/PDMR Shareholding
16th Sep 20147:30 amRNSDividend Declaration
16th Sep 20147:00 amRNSHalf Yearly Report
15th Jul 20147:00 amRNSInterim Management Statement
20th Jun 20144:02 pmRNSResult of AGM
19th May 20149:20 amRNSMAGNA MENA FUND REACHES 3 YEAR ANNIVERSARY
14th May 20142:38 pmRNSNotice of AGM
14th May 20147:00 amRNSDirector/PDMR Shareholding
9th May 20148:16 amRNSTriple Lipper Award Win for Charlemagne Capital
28th Apr 20143:27 pmRNSChange to Significant Shareholding
25th Apr 201412:49 pmRNSHolding(s) in Company
25th Apr 201410:30 amRNSHolding(s) in Company
8th Apr 20147:00 amRNSQ1 2014 AUM Update
18th Mar 20147:05 amRNSDividend Declaration
18th Mar 20147:00 amRNSFinal Results
14th Jan 20144:12 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.